Due to its multifaceted biological activity, it is a staple in advanced comparative studies involving the regeneration of skeletal muscle fibers, tendons, and ligaments
A May 2026 Lancet trial found semaglutide reduced heavy drinking days by 41% versus 26% on placebo in patients with alcohol use disorder and obesity, but the drug is not FDA-approved for this use
Hot flashes, night sweats, mood swings, sleep disturbances, and vaginal dryness top the list of complaints
A trade group representing independent pharmacies indicated the details are still developing, but the goal is to eventually bring U.S
Welcome to Hospitalogy, a newsletter breaking down healthcare finance, M&A, and strategy twice weekly